Pictet Asset Management Holding Sa Gilead Sciences, Inc. Transaction History
Pictet Asset Management Holding Sa
- $98.2 Billion
- Q3 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 2,683,400 shares of GILD stock, worth $333 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
2,683,400
Previous 2,637,119
1.75%
Holding current value
$333 Million
Previous $292 Million
1.87%
% of portfolio
0.3%
Previous 0.31%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,386Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...